Cugnenc PH - Search Results

1

Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples.

de Waziers I, Cugnenc PH, Berger A, Leroux JP, Beaune PH. de Waziers I, et al. Among authors: cugnenc ph. Carcinogenesis. 1991 May;12(5):905-9. doi: 10.1093/carcin/12.5.905. Carcinogenesis. 1991. PMID: 2029756

2

Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

de Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH. de Waziers I, et al. Among authors: cugnenc ph. J Pharmacol Exp Ther. 1990 Apr;253(1):387-94. J Pharmacol Exp Ther. 1990. PMID: 2329521

3

Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance.

Pagès F, Berger A, Henglein B, Piqueras B, Danel C, Zinzindohoue F, Thiounn N, Cugnenc PH, Fridman WH. Pagès F, et al. Among authors: cugnenc ph. Int J Cancer. 1999 Jun 21;84(3):326-30. doi: 10.1002/(sici)1097-0215(19990621)84:3<326::aid-ijc22>3.0.co;2-k. Int J Cancer. 1999. PMID: 10371355

4

CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines.

Gervot L, Carrière V, Costet P, Cugnenc PH, Berger A, Beaune PH, de Waziers I. Gervot L, et al. Among authors: cugnenc ph. Environ Toxicol Pharmacol. 1996 Dec 20;2(4):381-8. doi: 10.1016/s1382-6689(96)00075-0. Environ Toxicol Pharmacol. 1996. PMID: 21781746

5

[Evaluation and interest in new molecular markers in colon cancer].

Le Maire V, Sales JP, Wind P, Dumas F, Landi B, Fayemendy L, Cugnenc PH, Gayral F, Lacour B, Loric S. Le Maire V, et al. Among authors: cugnenc ph. Ann Pharm Fr. 1998;56(1):9-17. Ann Pharm Fr. 1998. PMID: 9770030 French.

6

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Among authors: cugnenc ph. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803

7

Interleukin-18: biological properties and clinical implications.

Lebel-Binay S, Berger A, Zinzindohoué F, Cugnenc P, Thiounn N, Fridman WH, Pagès F. Lebel-Binay S, et al. Eur Cytokine Netw. 2000 Mar;11(1):15-26. Eur Cytokine Netw. 2000. PMID: 10705295 Review.

8

Proinflammatory and antitumor properties of interleukin-18 in the gastrointestinal tract.

Pages F, Berger A, Lebel-Binay S, Zinzindohoue F, Danel C, Piqueras B, Carriere O, Thiounn N, Cugnenc PH, Fridman WH. Pages F, et al. Among authors: cugnenc ph. Immunol Lett. 2000 Dec 1;75(1):9-14. doi: 10.1016/s0165-2478(00)00285-6. Immunol Lett. 2000. PMID: 11163860 Review.

9

Analysis of interleukin-18, interleukin-1 converting enzyme (ICE) and interleukin-18-related cytokines in Crohn's disease lesions.

Pagès F, Lazar V, Berger A, Danel C, Lebel-Binay S, Zinzindohoué F, Desreumaux P, Cellier C, Thiounn N, Bellet D, Cugnenc PH, Fridman WH. Pagès F, et al. Among authors: cugnenc ph. Eur Cytokine Netw. 2001 Mar;12(1):97-104. Eur Cytokine Netw. 2001. PMID: 11282552

10

High levels of DNA adducts in human colon are associated with colorectal cancer.

Pfohl-Leszkowicz A, Grosse Y, Carrière V, Cugnenc PH, Berger A, Carnot F, Beaune P, de Waziers I. Pfohl-Leszkowicz A, et al. Among authors: cugnenc ph. Cancer Res. 1995 Dec 1;55(23):5611-6. Cancer Res. 1995. PMID: 7585642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results